• 100 jobs to be created within first 12 months
  • More than 9,000m² of specialised lab and office space to be made available
  • First tenant already identified for revamped site

More than 200 jobs will be created through a £4.6m investment in revamping laboratory space at Charnwood Campus. Highly-specialised lab space, which is currently unused, is to be reactivated to create a world-class biochemistry building. The project will enable a research organisation to expand into the LLEP area. It will mean existing facilities can be upgraded as part of the first phase of an Innovation Centre project which will provide specialised laboratories – which meet modern regulatory requirements – for Leicester and Leicestershire’s life sciences cluster. The total investment of £4.6m will be provided through Enterprise Zone Retained Rates Funding from the Leicester and Leicestershire Enterprise Partnership (LLEP), in partnership with Charnwood Borough Council.

Andy Reed OBE, LLEP Co-Chair, said: “This lab space will bring inward investment through the arrival of the first tenant. But it will also support the development and growth of businesses in the pharmaceutical, biotech, and medtech sectors by offering research, development, and small batch manufacturing capacity here in Leicestershire.”

The project will:

  • Make available 9,417m² of highly specialised biochemistry laboratory and office space
  • Create 100 high-value jobs within 12 months – and a total of 222 within five years
  • Introduce a further 1,110 jobs in the supply chain
  • Create 50 parking spaces with electric car charging points

Cllr Jewel Miah, Leader of Charnwood Borough Council said: “This project is another example of the opportunity we have to bring significant inward investment to Charnwood through making effective use of world-class life sciences infrastructure. Not only will this create cutting-edge lab space, it will also create hundreds of quality jobs and strengthen the supply chain for our local economy.”

Gosia Khrais, Commercial and Marketing Director at Charnwood Campus, said: “This investment will help accelerate our ambition to become a meaningful life sciences asset in the region, attracting inward investment, and providing employment directly on the site and within our local supply chain.

The project will also allow us to bring forward some of the other schemes that we have been working on in the background. None of this could have happened without really successful partnerships with our local and regional authorities. If you are looking for lab or office space to expand into, please reach out to us and we will be pleased to accommodate.”

Charnwood Campus was the UK’s first Life Sciences Opportunity Zone (LSOZ) and forms part of the Loughborough and Leicester Science and Innovation Enterprise Zone. Located on the former

AstraZeneca campus on the outskirts of Loughborough provides an ecosystem of businesses, leading research institutes, and government organisations. Its purpose is to grow med-tech and biopharma businesses by simplifying and accelerating the pathway from concept to commercialisation. Charnwood Campus covers 70 acres of development land, with laboratories and production plants designed for drug discovery and development.

Latest Opportunities

Study brief: The effects of a recovery gel on endurance cycling performance in the heat

The popularity of endurance sports like cycling and running has grown significantly over the past…

UKRI unveils new £9 million proof-of-concept fund

The UKRI Proof of Concept funding opportunity aims to support and accelerate the development of…

Peer advice on “demand forecasting strategies”

An established Midlands-based health manufacturer is keen to hear from others about their demand forecasting…

Latest News

Illuminating biology: Advanced imaging and computational techniques transforming medical research at the University of Warwick

Advances in imaging and computational techniques are enabling researchers to discover more than ever before…

From firefighting to future-proofing: Why predictive compliance is key in medical device software

By Medilink Midlands Member Coauthor by Hindsight In today’s fast-paced and highly regulated world of…

IMed Consultancy new whitepaper reveals how to transform gruelling PMS procedures into commercial benefit

IMed Consultancy’s new free whitepaper, “PMS from pain to potential: more than just ticking a…